MetaCap

Oramed Pharmaceuticals Insider Trades

NASDAQ: ORMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.33+0.13 (+3.10%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
4 · $1.17M
Shares bought / sold
0 / 260.36K
Net activity
Net selling $1.2 million

Oramed Pharmaceuticals insider activity

Over the last 12 months, Oramed Pharmaceuticals insiders reported 40 transactions on SEC Form 4: 0 open-market purchases and 4 sales. Insiders bought $0 and sold $1.2 million worth of stock, for net insider selling of $1.2 million. The largest seller was Hexter Joshua, with $746,761 in reported sales.

The most recent filing shows Gabay Avraham (Chief Financial Officer) selling 20,000 shares at $4.51 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ORMP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ORMP insider transactions

Oramed Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Oct 1, 2026Hexter JoshuaCOO & CBOSale30,000$135.33KForm 4
Oct 1, 2026Gabay AvrahamChief Financial OfficerSale20,000$90.20KForm 4
Sep 24, 2026Gabay AvrahamChief Financial OfficerAward209,291—Form 4
Sep 24, 2026Kidron MiriamChief Scientific OfficerAward209,291—Form 4
Sep 24, 2026Kidron MiriamChief Scientific OfficerAward208,125—Form 4
Sep 24, 2026Hexter JoshuaCOO & CBOAward209,291—Form 4
Sep 24, 2026Hexter JoshuaCOO & CBOAward75,455—Form 4
Sep 24, 2026KIDRON NADAVPresident and CEOAward368,765—Form 4
Sep 24, 2026KIDRON NADAVPresident and CEOAward349,497—Form 4
Jul 2, 2026Hexter JoshuaCOO & CBOOption exercise50,000$184.50KForm 4
Jul 1, 2026Gabay AvrahamChief Financial OfficerSale73,360$330.74KForm 4
Jul 1, 2026Hexter JoshuaCOO & CBOSale137,000$611.43KForm 4
Mar 30, 2026Kidron MiriamChief Scientific OfficerTax withholding435,084$1.44MForm 4
Mar 30, 2026KIDRON NADAVPresident and CEOTax withholding44,818$148.35KForm 4
Mar 17, 2026Hexter JoshuaCOO & CBOAward95,889—Form 4
Mar 17, 2026Kidron MiriamChief Scientific OfficerAward119,558—Form 4
Mar 17, 2026Gabay AvrahamChief Financial OfficerAward95,889—Form 4
Mar 17, 2026KIDRON NADAVPresident and CEOAward167,005—Form 4
Mar 12, 2026KIDRON NADAVPresident and CEOGift100,000—Form 4
Jan 22, 2026KIDRON NADAVPresident and CEOOption exercise109,000—Form 4
Jan 22, 2026Hexter JoshuaCOO & CBOOption exercise19,000—Form 4
Jan 22, 2026Gabay AvrahamChief Financial OfficerOption exercise19,000—Form 4
Jan 22, 2026Kidron MiriamChief Scientific OfficerOption exercise19,000—Form 4
Jan 14, 2026Kidron MiriamChief Scientific OfficerGift86,166—Form 4
Dec 31, 2025Gabay AvrahamChief Financial OfficerAward115,000—Form 4
Dec 31, 2025Gabay AvrahamChief Financial OfficerAward81,216—Form 4
Dec 31, 2025Aghion DanielDirectorAward6,250—Form 4
Dec 31, 2025Aghion DanielDirectorAward30,000—Form 4
Dec 31, 2025Shapiro BenjaminDirectorAward3,500—Form 4
Dec 31, 2025Shapiro BenjaminDirectorAward30,000—Form 4
Dec 31, 2025Hexter JoshuaCOO & CBOAward115,000—Form 4
Dec 31, 2025Hexter JoshuaCOO & CBOAward97,328—Form 4
Dec 31, 2025Reznick YehudaDirectorAward6,250—Form 4
Dec 31, 2025Reznick YehudaDirectorAward30,000—Form 4
Dec 31, 2025Mayer ArieDirectorAward4,900—Form 4
Dec 31, 2025Mayer ArieDirectorAward30,000—Form 4
Dec 31, 2025Kidron MiriamChief Scientific OfficerAward115,000—Form 4
Dec 31, 2025Kidron MiriamChief Scientific OfficerAward121,331—Form 4
Dec 31, 2025KIDRON NADAVPresident and CEOAward327,000—Form 4
Dec 31, 2025KIDRON NADAVPresident and CEOAward232,640—Form 4
Jun 5, 2025Shapiro BenjaminDirectorAward4,650—Form 4
Jun 5, 2025Shapiro BenjaminDirectorAward30,000—Form 4
Jun 5, 2025Sank LeonardDirectorAward6,510—Form 4
Jun 5, 2025Sank LeonardDirectorAward30,000—Form 4
Jun 5, 2025Reznick YehudaDirectorAward8,370—Form 4
Jun 5, 2025Reznick YehudaDirectorAward30,000—Form 4
Jun 5, 2025Aghion DanielDirectorAward8,371—Form 4
Jun 5, 2025Aghion DanielDirectorAward30,000—Form 4
Jun 5, 2025Mayer ArieDirectorAward6,975—Form 4
Jun 5, 2025Mayer ArieDirectorAward30,000—Form 4
Feb 11, 2025Gabay AvrahamChief Financial OfficerAward42,000—Form 4
Feb 11, 2025Gabay AvrahamChief Financial OfficerAward34,000—Form 4
Feb 11, 2025KIDRON NADAVPresident and CEOAward100,000—Form 4
Feb 11, 2025KIDRON NADAVPresident and CEOAward186,000—Form 4
Feb 11, 2025KIDRON NADAVPresident and CEOAward141,000—Form 4
Feb 11, 2025Hexter JoshuaCOO & CBOAward33,334—Form 4
Feb 11, 2025Hexter JoshuaCOO & CBOAward48,500—Form 4
Feb 11, 2025Hexter JoshuaCOO & CBOAward45,000—Form 4
Feb 11, 2025Kidron MiriamChief Scientific OfficerAward66,667—Form 4
Feb 11, 2025Kidron MiriamChief Scientific OfficerAward52,000—Form 4
Feb 11, 2025Kidron MiriamChief Scientific OfficerAward74,000—Form 4
Jan 2, 2025Kidron MiriamChief Scientific OfficerAward207,000—Form 4
Jan 2, 2025Gabay AvrahamChief Financial OfficerAward188,000—Form 4
Jan 2, 2025KIDRON NADAVPresident and CEOAward433,500—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related